Let’s Fight for a Billion-Worth Market
At Investment Forum held in Tuymen, President of JSC Pharmsintez Victram Singh Punia told about the company plans to conquer the American pharmaceutical market.
Work on development of a drug for treatment of postoperative adhesions is ongoing. There are no global equivalents to that. Currently the development is at the stage of clinical trials in Russian and European clinics. If it is successfully completed, i.e. the effectiveness of the new drug is proved, it will be offered in the global market.
The management of JSC Pharmsinez is negotiating on localization of manufacture with Finnish Orion Pharma, German Pfizer. It is planned to open manufacture of a drug for HIV infection and tablets for diabetes before the year end.
In near future Pharmsintez will submit an application for obtaining an FDA certificate.